From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Cardiology>
  4. Summary and Comment

Offer Flu Vaccine in Your Cardiology Practice

The AHA and ACC have jointly published a detailed, practical science advisory recommending flu vaccination for secondary prevention of cardiovascular disease.

Survey results show that the majority of cardiac patients are not being vaccinated against influenza, prompting the American Heart Association and American College of Cardiology to provide more detailed guidance about meeting this evidence-based standard of care. A new AHA/ACC advisory features a simple table outlining how providers can obtain flu vaccine in the U.S.

Influenza vaccination protects against cardiovascular events in patients with known CVD, according to evidence from multiple studies, including the randomized, controlled FLUVACS trial (Journal Watch Cardiology Jul 26 2002). Consistent with that evidence, the CDC recommends annual influenza vaccination in patients with CVD (MMWR Recomm Rep 2006; 55:1). Current secondary-prevention guidelines from the AHA and ACC also include a class I recommendation for flu vaccine in patients with coronary and other atherosclerotic vascular disease (Journal Watch Cardiology Jun 8 2006). In this population, inactivated flu vaccine should be administered intramuscularly; intranasally administered live vaccine is contraindicated.

Comment: The clear benefit of influenza vaccination for heart patients obliges the cardiovascular-care community to provide all appropriate patients with the opportunity to be vaccinated. Toward that end, cardiology practices should stock flu vaccine and offer it to those who will benefit from it.

— Harlan M. Krumholz, MD, SM

Dr. Krumholz was the senior member of the writing group for this AHA/ACC advisory.

Published in Journal Watch Cardiology October 11, 2006

Citation(s):

Davis MM et al. Influenza vaccination as secondary prevention for cardiovascular disease: A science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol 2006 Oct 3; 48:1498-502.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2006. Massachusetts Medical Society. All rights reserved.